FR2784377B3 - Nouveaux composes derives d'ureidopiperidine, antagonistes selectifs des recepteurs nk3 humains, procede pour leur obtention et compositions pharmaceutiques les contenant - Google Patents

Nouveaux composes derives d'ureidopiperidine, antagonistes selectifs des recepteurs nk3 humains, procede pour leur obtention et compositions pharmaceutiques les contenant

Info

Publication number
FR2784377B3
FR2784377B3 FR9812859A FR9812859A FR2784377B3 FR 2784377 B3 FR2784377 B3 FR 2784377B3 FR 9812859 A FR9812859 A FR 9812859A FR 9812859 A FR9812859 A FR 9812859A FR 2784377 B3 FR2784377 B3 FR 2784377B3
Authority
FR
France
Prior art keywords
ureidopiperidine
receptors
human
production
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9812859A
Other languages
English (en)
Other versions
FR2784377A1 (fr
Inventor
Alt Xavier Emonds
Vincenzo Proietto
Broeck Didier Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9812859A priority Critical patent/FR2784377B3/fr
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to JP2000575840A priority patent/JP2002527423A/ja
Priority to YU26001A priority patent/YU26001A/sh
Priority to US09/806,878 priority patent/US6465489B1/en
Priority to AU59887/99A priority patent/AU751592B2/en
Priority to IL14236299A priority patent/IL142362A0/xx
Priority to CA002346729A priority patent/CA2346729A1/fr
Priority to PL99347910A priority patent/PL347910A1/xx
Priority to KR1020017004456A priority patent/KR20010085903A/ko
Priority to TR2001/01030T priority patent/TR200101030T2/xx
Priority to EA200100299A priority patent/EA003613B1/ru
Priority to BR9914397-6A priority patent/BR9914397A/pt
Priority to HU0201709A priority patent/HUP0201709A3/hu
Priority to EEP200100214A priority patent/EE200100214A/xx
Priority to SK464-2001A priority patent/SK4642001A3/sk
Priority to PCT/FR1999/002355 priority patent/WO2000021931A1/fr
Priority to CNB998142085A priority patent/CN1133622C/zh
Priority to EP99970379A priority patent/EP1119552A1/fr
Priority to NZ510779A priority patent/NZ510779A/en
Priority to TW088117155A priority patent/TW539669B/zh
Priority to DZ990205A priority patent/DZ2905A1/fr
Priority to ARP990105081A priority patent/AR029148A1/es
Priority to CO99064055A priority patent/CO5180555A1/es
Publication of FR2784377A1 publication Critical patent/FR2784377A1/fr
Application granted granted Critical
Publication of FR2784377B3 publication Critical patent/FR2784377B3/fr
Priority to IS5897A priority patent/IS5897A/is
Priority to NO20011779A priority patent/NO20011779L/no
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
FR9812859A 1998-10-09 1998-10-09 Nouveaux composes derives d'ureidopiperidine, antagonistes selectifs des recepteurs nk3 humains, procede pour leur obtention et compositions pharmaceutiques les contenant Expired - Lifetime FR2784377B3 (fr)

Priority Applications (25)

Application Number Priority Date Filing Date Title
FR9812859A FR2784377B3 (fr) 1998-10-09 1998-10-09 Nouveaux composes derives d'ureidopiperidine, antagonistes selectifs des recepteurs nk3 humains, procede pour leur obtention et compositions pharmaceutiques les contenant
CNB998142085A CN1133622C (zh) 1998-10-09 1999-10-04 脲基哌啶衍生物作为人类nk3受体的选择性拮抗剂
PCT/FR1999/002355 WO2000021931A1 (fr) 1998-10-09 1999-10-04 Derives d'ureidopiperidine comme antagonistes selectifs des recepteurs nk3 humains
AU59887/99A AU751592B2 (en) 1998-10-09 1999-10-04 Ureidopiperidine derivatives as selective human NK3 receptor antagonists
YU26001A YU26001A (sh) 1998-10-09 1999-10-04 Derivati ureidopiperidina kao selektivni antagonisti ljudskih nk3 receptora
CA002346729A CA2346729A1 (fr) 1998-10-09 1999-10-04 Derives d'ureidopiperidine comme antagonistes selectifs des recepteurs nk3 humains
PL99347910A PL347910A1 (en) 1998-10-09 1999-10-04 Ureidopiperidine derivatives as selective human nk3
KR1020017004456A KR20010085903A (ko) 1998-10-09 1999-10-04 선택적 인간 ｎｋ3 수용체 길항제로서의 우레이도피페리딘유도체
TR2001/01030T TR200101030T2 (tr) 1998-10-09 1999-10-04 İnsanlara özgü NK3 reseptörlerinin seçici antagonistleri olarak üreidopiperidin türevleri
EA200100299A EA003613B1 (ru) 1998-10-09 1999-10-04 Уреидопиперидиновые производные как селективные антагонисты nk3-рецепторов человека
BR9914397-6A BR9914397A (pt) 1998-10-09 1999-10-04 Derivados da ureidopiperidina como antagonistas seletivos dos receptores nk3 humanos
EP99970379A EP1119552A1 (fr) 1998-10-09 1999-10-04 Derives d'ureidopiperidine comme antagonistes selectifs des recepteurs nk 3? humains
JP2000575840A JP2002527423A (ja) 1998-10-09 1999-10-04 ヒトｎｋ３受容体の選択的アンタゴニストとしてのウレイドピペリジン誘導体
SK464-2001A SK4642001A3 (en) 1998-10-09 1999-10-04 Ureidopiperidine derivatives their preparation and use
US09/806,878 US6465489B1 (en) 1998-10-09 1999-10-04 Ureidopiperidine derivatives as selective human NK3 receptor antagonists
IL14236299A IL142362A0 (en) 1998-10-09 1999-10-04 Ureidopiperidine derivatives as selective human nk3 receptor antagonists
HU0201709A HUP0201709A3 (en) 1998-10-09 1999-10-04 Ureidopiperidine derivatives as selective human nk3 receptor antagonists, pharmaceutical compositions containing them and use of them for producing pharmaceutical compositions
NZ510779A NZ510779A (en) 1998-10-09 1999-10-04 Ureidopiperidine derivatives useful as selective human NK 3 receptor antagonists
EEP200100214A EE200100214A (et) 1998-10-09 1999-10-04 Ureidopiperidiini derivaadid kui inimese NK3 retseptorite selektiivsed antagonistid
TW088117155A TW539669B (en) 1998-10-09 1999-10-05 New compounds derived from ureidopiperidine, selective antagonists of human NK3 receptors, process for obtaining them and pharmaceutical compositions containing them
DZ990205A DZ2905A1 (fr) 1998-10-09 1999-10-06 Nouveaux composés dérivés d'ureidopipéridine, ant agonistes sélectifs des récepteurs nk3 humains, procédé pour leur obtention et compositions pharmaceutiques les contenant.
ARP990105081A AR029148A1 (es) 1998-10-09 1999-10-07 Compuestos derivados de ureido piperidina, procedimiento para su obtencion, compuestos intermediarios, composiciones farmaceuticas que los contienen, y el uso de los mismos para la preparacion de medicamentos
CO99064055A CO5180555A1 (es) 1998-10-09 1999-10-08 Nuevos compuestos derivados de ureido piperidina, antagonistas selectivos de los receptores nk, humanos, procedimiento para su obtencion y composiciones farmaceuti- cas que los contienen
IS5897A IS5897A (is) 1998-10-09 2001-03-16 Úreídópíperidín afleiður sem valvís NK3 viðtakamótlyf fyrir manneskjur
NO20011779A NO20011779L (no) 1998-10-09 2001-04-06 Ureidopiperidinderivater som selektive humane NK3 reseptor antagonister

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9812859A FR2784377B3 (fr) 1998-10-09 1998-10-09 Nouveaux composes derives d'ureidopiperidine, antagonistes selectifs des recepteurs nk3 humains, procede pour leur obtention et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
FR2784377A1 FR2784377A1 (fr) 2000-04-14
FR2784377B3 true FR2784377B3 (fr) 2000-11-17

Family

ID=9531536

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9812859A Expired - Lifetime FR2784377B3 (fr) 1998-10-09 1998-10-09 Nouveaux composes derives d'ureidopiperidine, antagonistes selectifs des recepteurs nk3 humains, procede pour leur obtention et compositions pharmaceutiques les contenant

Country Status (25)

Country Link
US (1) US6465489B1 (fr)
EP (1) EP1119552A1 (fr)
JP (1) JP2002527423A (fr)
KR (1) KR20010085903A (fr)
CN (1) CN1133622C (fr)
AR (1) AR029148A1 (fr)
AU (1) AU751592B2 (fr)
BR (1) BR9914397A (fr)
CA (1) CA2346729A1 (fr)
CO (1) CO5180555A1 (fr)
DZ (1) DZ2905A1 (fr)
EA (1) EA003613B1 (fr)
EE (1) EE200100214A (fr)
FR (1) FR2784377B3 (fr)
HU (1) HUP0201709A3 (fr)
IL (1) IL142362A0 (fr)
IS (1) IS5897A (fr)
NO (1) NO20011779L (fr)
NZ (1) NZ510779A (fr)
PL (1) PL347910A1 (fr)
SK (1) SK4642001A3 (fr)
TR (1) TR200101030T2 (fr)
TW (1) TW539669B (fr)
WO (1) WO2000021931A1 (fr)
YU (1) YU26001A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068604A2 (fr) 2000-03-14 2001-09-20 Sepracor, Inc. Piperidines 3-substituees comprenant un groupement uree et procedes d'utilisation de ces dernieres
US20060128752A1 (en) * 2002-07-03 2006-06-15 Giuseppe Alvaro Chemical compounds
US20110144081A1 (en) * 2009-12-15 2011-06-16 Henner Knust Pyrrolidine derivatives
US9554659B2 (en) 2012-10-22 2017-01-31 Uwm Research Foundation, Inc. Infant sleep pod
US20210401821A1 (en) * 2018-11-15 2021-12-30 Kyushu University, National University Corporation Prophylactic or therapeutic agent and medicinal composition for il-31-mediated disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2676055B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
FR2719311B1 (fr) 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2738819B1 (fr) 1995-09-14 1997-12-05 Sanofi Sa Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
AU4176997A (en) * 1996-09-16 1998-04-02 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines

Also Published As

Publication number Publication date
CN1329594A (zh) 2002-01-02
WO2000021931A1 (fr) 2000-04-20
HUP0201709A2 (en) 2002-09-28
BR9914397A (pt) 2001-06-26
EA200100299A1 (ru) 2001-10-22
TW539669B (en) 2003-07-01
PL347910A1 (en) 2002-04-22
FR2784377A1 (fr) 2000-04-14
EP1119552A1 (fr) 2001-08-01
NZ510779A (en) 2003-07-25
AR029148A1 (es) 2003-06-18
EA003613B1 (ru) 2003-06-26
NO20011779D0 (no) 2001-04-06
JP2002527423A (ja) 2002-08-27
CA2346729A1 (fr) 2000-04-20
KR20010085903A (ko) 2001-09-07
DZ2905A1 (fr) 2004-03-01
NO20011779L (no) 2001-06-07
IS5897A (is) 2001-03-16
SK4642001A3 (en) 2001-09-11
AU5988799A (en) 2000-05-01
EE200100214A (et) 2002-08-15
US6465489B1 (en) 2002-10-15
TR200101030T2 (tr) 2001-08-21
AU751592B2 (en) 2002-08-22
IL142362A0 (en) 2002-03-10
YU26001A (sh) 2003-04-30
HUP0201709A3 (en) 2003-03-28
CO5180555A1 (es) 2002-07-30
CN1133622C (zh) 2004-01-07

Similar Documents

Publication Publication Date Title
MA26686A1 (fr) Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26638A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compoositions pharmaceutiques les contenant
FR2740136B1 (fr) Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
MA26712A1 (fr) Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26620A1 (fr) Derives bicycliques d'acide hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26439A1 (fr) Derives d'indazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2742148B1 (fr) Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2729951B1 (fr) Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
MA26687A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26465A1 (fr) Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26675A1 (fr) Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2890A1 (fr) 4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26526A1 (fr) Derives d'indole inhibiteurs de cyclo-oxygenase, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26611A1 (fr) Composes heterocycliques nouveaux inhibiteurs de romatases, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26428A1 (fr) Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant
MA23831A1 (fr) Derives de quinazoline, procede pour leur preparation et composition les contenant
MA26432A1 (fr) Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA24158A1 (fr) Derives d'imidazole substitues, procede pour leur preparation et compositions les contenant
MA26624A1 (fr) Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2794742B1 (fr) Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant
MA26558A1 (fr) Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26588A1 (fr) Derives d'erythromycine nouveaux, procede et intermediaires pour leur preparation, et compositions pharmaceutiques les contenant
FR2810320B1 (fr) Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
FR2805536B1 (fr) Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
MA26501A1 (fr) Derives de quinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
TP Transmission of property